Patents by Inventor Thomas A. Sanderson
Thomas A. Sanderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240124308Abstract: A compound represented by one of the formulae: BaaMobOc??(1), MOdPeOf??(2) or BagMohPiOj??(3) wherein for formula (1) the ratio of a:b is from 1:100 to 100:1, wherein for formula (2) the ratio of d:e is from 1:100 to less than 1:1 or from greater than 1:1 to 100:1, wherein for formula (3) the ratio of g:h is from 1:100 to less than 1.5:1, wherein for formula (3) the ratio of g:i is from 1:100 to 100:1, wherein for formula (3) the ratio of h:i is from 1:100 to less than 1:2, or from greater than 1:2 to less than 2:1, or from greater than 2:1 to 100:1, and wherein the molybdenum present within the compound is in the 5+ oxidation state.Type: ApplicationFiled: October 12, 2023Publication date: April 18, 2024Inventors: Kevin Sanderson, Anna Colley, John Hodgkinson, David Strickler, Lila Dahal, Vikash Ranjan, Matthew Rosseinsky, Matthew Dyer, Dihao Zeng, Guopeng Han, Jonathon Alaria, Troy Manning, Thomas Beesley, Anna Krowitz
-
Publication number: 20240124351Abstract: A compound represented by one of the formulae: BaaMobOc??(1), MOdPeOf??(2) or BagMohPiOj??(3) wherein for formula (1) the ratio of a:b is greater than 1:1, wherein for formula (2) the ratio of d:e is from 1:100 to 0.45:1 or from 0.55:1 to 100:1, wherein for formula (3) the ratio of g:h is from 1:7 to 1:2 and the ratio of g:i is from 1:3 to 1:1, or the ratio of g:h is from 0.6:1 to 100:1 and the ratio of g:i is from 2.2:1 to 100:1, and wherein the molybdenum present within the compound is in the 4+ oxidation state.Type: ApplicationFiled: October 12, 2023Publication date: April 18, 2024Inventors: Kevin Sanderson, Anna Colley, John Hodgkinson, David Strickler, Lila Dahal, Vikash Ranjan, Matthew Rosseinsky, Dihao Zeng, Matthew Dyer, Guopeng Han, Jonathon Alaria, Troy Manning, Thomas Beesley, Anna Krowitz
-
Patent number: 11936991Abstract: An EO/IR optical imaging system comprises collection optics to collect light from a scene into a collimated or near-collimated space. An imaging detector is positioned at the image plane and configured to integrate incident light (radiant flux or photons) over an image frame and readout a sequence of pixelated images at a frame rate, said detector exhibiting a saturation threshold. To prevent saturation of the imaging detector, a MEMS MMA is positioned in the collimated or near-collimated space. A secondary detector (via a pick-off) samples light from the collimated or near-collimated space multiple times per image frame. A controller responsive to the sampled light commands a percentage of the mirrors to re-direct light incident on those mirrors to a light dump and commands the remaining mirrors to re-direct light incident on those mirrors to the imaging detector.Type: GrantFiled: August 9, 2021Date of Patent: March 19, 2024Assignee: Raytheon CompanyInventors: Andrew M. Wilds, Craig O. Shott, Thomas Sanderson
-
Publication number: 20230058098Abstract: An optics system includes a convex catching mirror located within respect to the concave primary mirror to form an optical path for a field of view. A conical volume is formed with respect to the concave primary mirror and the convex catching mirror, the optical path not obstructed by the conical volume. A component within the conical volume.Type: ApplicationFiled: August 18, 2021Publication date: February 23, 2023Applicant: Raytheon CompanyInventor: Thomas Sanderson
-
Publication number: 20230043382Abstract: An EO/IR optical imaging system comprises collection optics to collect light from a scene into a collimated or near-collimated space. An imaging detector is positioned at the image plane and configured to integrate incident light (radiant flux or photons) over an image frame and readout a sequence of pixelated images at a frame rate, said detector exhibiting a saturation threshold. To prevent saturation of the imaging detector, a MEMS MMA is positioned in the collimated or near-collimated space. A secondary detector (via a pick-off) samples light from the collimated or near-collimated space multiple times per image frame. A controller responsive to the sampled light commands a percentage of the mirrors to re-direct light incident on those mirrors to a light dump and commands the remaining mirrors to re-direct light incident on those mirrors to the imaging detector.Type: ApplicationFiled: August 9, 2021Publication date: February 9, 2023Inventors: Andrew M. Wilds, Craig O. Shott, Thomas Sanderson
-
Patent number: 11020604Abstract: A method of treating an ischemic event in tissue of a subject in need thereof, includes applying light to a tissue susceptible to ischemic reperfusion injury, the light having a wavelength selected from two wavelength ranges selected from 730-770 nm, 850-890 nm, 880-920 nm, and 930-970 nm, thereby to reduce ischemic reperfusion injury in the tissue of the subject.Type: GrantFiled: June 27, 2018Date of Patent: June 1, 2021Assignee: Wayne State UniversityInventors: Maik Huttemann, Thomas Sanderson, John Kamholz, Kwaku Nantwi, Karin Przyklenk, Icksoo Lee, Lawrence Grossman
-
Publication number: 20180304091Abstract: A method of treating an ischemic event in tissue of a subject in need thereof, includes applying light to a tissue susceptible to ischemic reperfusion injury, the light having a wavelength selected from two wavelength ranges selected from 730-770 nm, 850-890 nm, 880-920 nm, and 930-970 nm, thereby to reduce ischemic reperfusion injury in the tissue of the subject.Type: ApplicationFiled: June 27, 2018Publication date: October 25, 2018Inventors: Maik Huttemann, Thomas Sanderson, John Kamholz, Kwaku Nantwi, Karin Przyklenk, Icksoo Lee, Lawrence Grossman
-
Patent number: 10071261Abstract: A light therapy method, comprising identifying a pathological condition in a patient, selecting at least one light wavelength based on the identified pathological condition, and applying one or a combination of the selected light wavelengths to the patient using a light source.Type: GrantFiled: May 12, 2015Date of Patent: September 11, 2018Assignee: Wayne State UniversityInventors: Maik Huttemann, Thomas Sanderson, John Kamholz, Kwaku Nantwi, Karin Przyklenk, Icksoo Lee, Lawrence Grossman
-
Patent number: 9610460Abstract: An exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event. Applying the light to the tissue inhibits cytochrome c oxidase activity. Another exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event and prior to either reoxygenation of the tissue or clinical intervention to reduce cell damage. An exemplary light therapy device includes at least one light source configured to generate light having a wavelength of at least one of approximately 730-770 nm, 850-890 nm, 880-920 nm, and 930-970 nm.Type: GrantFiled: August 29, 2014Date of Patent: April 4, 2017Assignee: Wayne State UniversityInventors: Maik Huttemann, Icksoo Lee, John Kamholz, Lawrence Grossman, Karin Przyklenk, Thomas Sanderson
-
Publication number: 20150246240Abstract: A light therapy method, comprising identifying a pathological condition in a patient, selecting at least one light wavelength based on the identified pathological condition, and applying one or a combination of the selected light wavelengths to the patient using a light source.Type: ApplicationFiled: May 12, 2015Publication date: September 3, 2015Inventors: Maik Huttemann, Thomas Sanderson, John Kamholz, Kwaku Nantwi, Karin Przyklenk, Icksoo Lee, Lawrence Grossman
-
Patent number: 8945196Abstract: An exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event. Applying the light to the tissue inhibits cytochrome c oxidase activity. Another exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event and prior to either reoxygenation of the tissue or clinical intervention to reduce cell damage. An exemplary light therapy device includes at least one light source configured to generate light having a wavelength of at least one of approximately 730-770 nm, 850-890 nm, 880-920 nm, and 930-970 nm.Type: GrantFiled: April 30, 2010Date of Patent: February 3, 2015Assignee: Wayne State UniversityInventors: Maik Huttemann, Icksoo Lee, John Kamholz, Lawrence Grossman, Karin Przyklenk, Thomas Sanderson
-
Publication number: 20140371826Abstract: An exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event. Applying the light to the tissue inhibits cytochrome c oxidase activity. Another exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event and prior to either reoxygenation of the tissue or clinical intervention to reduce cell damage. An exemplary light therapy device includes at least one light source configured to generate light having a wavelength of at least one of approximately 730-770 nm, 850-890 nm, 880-920 nm, and 930-970 nm.Type: ApplicationFiled: August 29, 2014Publication date: December 18, 2014Inventors: Maik Huttemann, Icksoo Lee, John Kamholz, Lawrence Grossman, Karin Przyklenk, Thomas Sanderson
-
Publication number: 20110066213Abstract: An exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event. Applying the light to the tissue inhibits cytochrome c oxidase activity. Another exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event and prior to either reoxygenation of the tissue or clinical intervention to reduce cell damage. An exemplary light therapy device includes at least one light source configured to generate light having a wavelength of at least one of approximately 730-770 nm, 850-890 nm, 880-920 nm, and 930-970 nm.Type: ApplicationFiled: April 30, 2010Publication date: March 17, 2011Inventors: Maik Huttermann, Icksoo Lee, John Kamholz, Lawrence Grossman, Karin Przyklenk, Thomas Sanderson
-
Patent number: 7796153Abstract: A system and method for equalizing an imaging sensor. The system includes at least one image sensor having a plurality of detectors defining a sensor array, each detector being configured to provide an output signal representative of a sensed image. The system further includes an equalization system configured to receive the output signals from the detectors; estimate a distribution for at least one detector based on the respective output signals; compare the distribution for the at least one of the detectors to a given distribution to determine a mapping function for the at least one detector; and apply the respective mapping function of the at least one detector to the output signal of the at least one detector to provide an equalized signal for the at least one detector.Type: GrantFiled: July 8, 2005Date of Patent: September 14, 2010Assignee: ITT Manufacturing Enterprises, Inc.Inventors: Thomas A. Sanderson, Scott A. Bennett, Kristo Miettinen
-
Publication number: 20060120051Abstract: A metal thermal interface structure for dissipating heat from electronic components comprised a heat spreader lid, metal alloy that is liquid over the operating temperature range of the electronic component, and design features to promote long-term reliability and high thermal performance.Type: ApplicationFiled: December 3, 2004Publication date: June 8, 2006Inventors: Chris Macris, Thomas Sanderson, Robert Ebel
-
Publication number: 20060118925Abstract: A metal thermal interface structure for dissipating heat from electronic components comprised a heat spreader lid, metal alloy that is liquid over the operating temperature range of the electronic component, and design features to promote long-term reliability and high thermal performance.Type: ApplicationFiled: October 11, 2005Publication date: June 8, 2006Inventors: Chris Macris, Thomas Sanderson, Robert Ebel
-
Patent number: 6717700Abstract: A method and system which converts an electronic binary image to another electronic binary image by compensating for the differences between printer responses so that a target printer can print the image to emulate how the image would appear if printed by an originally-intended printer or another printer. A print-ready binary image is inputted into a print and scan simulation circuit which electronically simulates the printing and scanning of the image data. The print and scan simulation circuit converts the binary image data to gray scale image data. The gray scale image data is then processed by a tone response correction circuit. The tone response correction circuit alters the gray scale image data based on the difference between the tone reproduction curves of two printers, such as an originally-intended printer and a target printer.Type: GrantFiled: July 1, 1999Date of Patent: April 6, 2004Assignee: Xerox CorporationInventors: Thomas A. Sanderson, Ying-wei Lin
-
Patent number: 5587164Abstract: A process for growing a PRRSV in a tissue culture which is susceptible to infection to replicate the virus to an amount sufficient to protect animals against PRRS or be used in diagnosing PRRS or identifying the molecular structure of PRRSV for development of recombinant products, comprising inoculating the virus onto the tissue culture and harvesting the replicated virus.Type: GrantFiled: December 6, 1994Date of Patent: December 24, 1996Assignees: Bayer Corporation, Iowa State University Research Foundation, Inc.Inventors: Thomas Sanderson, Michael J. McGinley, Jeffrey J. Zimmerman, Howard T. Hill, Michael C. Meetz, Eugene C. Pirtle, Sabrina L. Swenson, George P. Shibley
-
Patent number: 5510258Abstract: A process for growing a PRRSV in a tissue culture which is susceptible to infection and replication of PRRSV to an amount sufficient to protect animals against PRRS or be used in diagnosing PRRS or identifying the molecular structure of PRRSV for development of recombinant products, comprising inoculating the PRRSV onto the tissue culture and harvesting the replicated PRRSV.Type: GrantFiled: June 1, 1994Date of Patent: April 23, 1996Assignees: Bayer Corporation, Iowa State University Research FoundationInventors: Thomas Sanderson, Michael J. Mcginley, Jeffrey J. Zimmerman, Howard T. Hill, Michael C. Meetz, Eugene C. Pirtle, Sabrina L. Swenson, George P. Shibley
-
Patent number: 4477622Abstract: Disclosed are contact adhesives, containing aqueous polymeric latexes, particularly acrylic latexes. Contact adhesives are adhesives which dry to a non-tacky state but which will adhere to another surface of the same dried adhesive. A unique feature of the adhesives is that the polymer used therein has an extremely wide range of molecular weights with substantial proportions of the product having a low molecular weight and substantial portions having a very high molecular weight, preferably with fairly uniform progression from low molecular weight to high molecular weight. However, blends of a low molecular weight fraction and a high molecular weight polymer may also be used. The preferred procedure is to prepare an emulsion polymer by reacting part of the material in the reactor in such a way as to obtain a high molecular weight product and to react at least one other portion of the monomer in the same reactor in such a way as to obtain at least one low molecular weight fraction.Type: GrantFiled: September 11, 1981Date of Patent: October 16, 1984Assignee: Rohm and Haas CompanyInventors: F. Thomas. Sanderson, David R. Gehman